Plexus (NASDAQ:PLXS) Rating Lowered to Strong Sell at Zacks Research

Plexus (NASDAQ:PLXS) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Zacks Research also issued estimates for Plexus’ Q3 2026 earnings at $1.16 EPS, Q4 2026 earnings at $1.45 EPS, FY2026 earnings at $5.86 EPS, Q1 2027 earnings at $1.49 EPS, Q2 2027 earnings at $1.60 EPS, Q3 2027 earnings at $1.48 EPS, Q4 2027 earnings at $1.91 EPS, FY2027 earnings at $6.49 EPS, Q1 2028 earnings at $2.02 EPS, Q2 2028 earnings at $2.04 EPS and FY2028 earnings at $8.17 EPS.

Several other equities analysts have also recently weighed in on the company. Williams Trading set a $195.00 price objective on Plexus in a research note on Wednesday, January 28th. Weiss Ratings upgraded shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Stifel Nicolaus set a $250.00 price target on shares of Plexus and gave the company a “buy” rating in a research report on Monday, April 20th. Benchmark restated a “buy” rating and set a $220.00 price target on shares of Plexus in a research report on Monday, March 16th. Finally, Raymond James Financial restated an “outperform” rating and set a $275.00 price target on shares of Plexus in a research report on Thursday, April 30th. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $229.17.

Plexus Price Performance

Shares of NASDAQ:PLXS opened at $256.38 on Wednesday. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The stock’s fifty day simple moving average is $228.85 and its two-hundred day simple moving average is $189.62. Plexus has a 1-year low of $115.35 and a 1-year high of $275.83. The stock has a market cap of $6.86 billion, a PE ratio of 37.48 and a beta of 0.88.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.13 billion. During the same period last year, the business earned $1.66 EPS. The business’s revenue was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, analysts forecast that Plexus will post 5.97 EPS for the current fiscal year.

Insider Activity at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $195.59, for a total value of $97,795.00. Following the completion of the sale, the director owned 8,535 shares of the company’s stock, valued at approximately $1,669,360.65. This trade represents a 5.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Todd P. Kelsey sold 3,000 shares of Plexus stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $268.45, for a total value of $805,350.00. Following the completion of the sale, the chief executive officer directly owned 74,888 shares of the company’s stock, valued at approximately $20,103,683.60. This trade represents a 3.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 18,471 shares of company stock worth $4,719,291 in the last ninety days. Corporate insiders own 1.78% of the company’s stock.

Institutional Investors Weigh In On Plexus

Several large investors have recently added to or reduced their stakes in PLXS. American Century Companies Inc. increased its holdings in Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after acquiring an additional 338,119 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Plexus by 130.0% in the 4th quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock worth $51,311,000 after acquiring an additional 197,283 shares during the last quarter. Emerald Advisers LLC purchased a new stake in Plexus in the 1st quarter worth about $33,729,000. MetLife Investment Management LLC increased its holdings in Plexus by 713.3% in the 4th quarter. MetLife Investment Management LLC now owns 126,971 shares of the technology company’s stock worth $18,665,000 after acquiring an additional 111,360 shares during the last quarter. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in Plexus in the 1st quarter worth about $20,715,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.